This new article publication from Acta Pharmaceutica Sinica B, discusses how an innovative and stable mRNA-LNP microneedle vaccine elicits humoral and multifunctional cellular immune responses. During ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

RA patients on upadacitinib and methotrexate showed robust antibody and T-cell responses to the recombinant zoster vaccine over 60 weeks. The vaccine maintained a satisfactory humoral response in 71.4 ...

(L) co-corresponding author Octavio Ramilo, MD, St. Jude Department of Infectious Diseases chair and (R) co-first author Asunción Mejías, MD, PhD, MsCS, St. Jude Department of Infectious Diseases.

Young infants hospitalized with respiratory syncytial virus (RSV) often become much sicker than those infected with SARS-CoV-2, the virus that causes COVID-19. In a study published in Science ...

Study finds infants' immune systems respond very differently to the two viruses, with important treatment implications. MEMPHIS, Tenn. and FARMINGTON, Conn., Feb. 25, 2026 /PRNewswire/ -- Young ...